CNBX Pharmaceuticals, Inc. (CNBX)
0.0002
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
CNBX Pharmaceuticals Net Income (Quarterly) : -0.1542M for May 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.1542M |
| February 28, 2026 | -0.0441M |
| November 30, 2025 | -0.1137M |
| August 31, 2025 | -0.1501M |
| May 31, 2025 | -0.0597M |
| February 28, 2025 | -0.0698M |
| November 30, 2024 | -0.0344M |
| August 31, 2024 | -0.0606M |
| May 31, 2024 | -0.1306M |
| February 29, 2024 | -0.3255M |
| November 30, 2023 | -0.1785M |
| August 31, 2023 | -0.5736M |
| May 31, 2023 | -0.1547M |
| February 28, 2023 | -2.624M |
| November 30, 2022 | -0.3577M |
| August 31, 2022 | -0.4797M |
| May 31, 2022 | -0.6817M |
| February 28, 2022 | -1.239M |
| November 30, 2021 | -1.323M |
| August 31, 2021 | -0.6812M |
| May 31, 2021 | -1.324M |
| February 28, 2021 | -0.5348M |
| November 30, 2020 | -0.6548M |
| August 31, 2020 | -0.7317M |
| May 31, 2020 | -0.7257M |
| Date | Value |
|---|---|
| February 29, 2020 | -0.8679M |
| November 30, 2019 | -5.142M |
| August 31, 2019 | -1.393M |
| May 31, 2019 | -0.5474M |
| February 28, 2019 | 3.730M |
| November 30, 2018 | -0.656M |
| August 31, 2018 | -0.7323M |
| May 31, 2018 | -0.8718M |
| February 28, 2018 | -1.635M |
| November 30, 2017 | -0.5375M |
| August 31, 2017 | -1.103M |
| May 31, 2017 | -0.2454M |
| February 28, 2017 | -0.4383M |
| November 30, 2016 | -0.147M |
| August 31, 2016 | -0.0685M |
| May 31, 2016 | -0.0265M |
| February 29, 2016 | -0.1469M |
| November 30, 2015 | -0.0553M |
| August 31, 2015 | -0.2049M |
| May 31, 2015 | -0.1538M |
| February 28, 2015 | -0.0566M |
| November 30, 2014 | -0.1277M |
| May 31, 2014 | -0.0559M |
| February 28, 2014 | -0.0322M |
| November 30, 2013 | -0.0133M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.164M |
| Arvinas, Inc. | 169.40M |
| Fulcrum Therapeutics, Inc. | -26.18M |
| Definium Therapeutics, Inc. | -158.99M |
| LeonaBio, Inc. | -19.01M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.1542M |
| EPS Diluted (Quarterly) | -0.0001 |
| Enterprise Value | 1.379M |
| Earnings Yield | -400.0% |
| Normalized Earnings Yield | -400.00 |